Cargando…
Assessment of Initial Vancomycin Dosing in Pediatric Oncology Patients
This was a retrospective audit assessing vancomycin dosing of 60 mg/kg/day in the attainment of therapeutic concentrations between 10–20 mcg/mL among 56 pediatric oncology patients. Twelve patients (21%) achieved therapeutic concentrations of 10–20 mcg/mL, while 44 patients (79%) obtained trough lev...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5615269/ https://www.ncbi.nlm.nih.gov/pubmed/28846665 http://dx.doi.org/10.3390/children4090079 |
_version_ | 1783266552786714624 |
---|---|
author | Orr, Hillary Trone, Deni Elder, Joshua Raj, Ashok |
author_facet | Orr, Hillary Trone, Deni Elder, Joshua Raj, Ashok |
author_sort | Orr, Hillary |
collection | PubMed |
description | This was a retrospective audit assessing vancomycin dosing of 60 mg/kg/day in the attainment of therapeutic concentrations between 10–20 mcg/mL among 56 pediatric oncology patients. Twelve patients (21%) achieved therapeutic concentrations of 10–20 mcg/mL, while 44 patients (79%) obtained trough levels below 10 mcg/mL despite the addition of nephrotoxic agents. |
format | Online Article Text |
id | pubmed-5615269 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-56152692017-09-28 Assessment of Initial Vancomycin Dosing in Pediatric Oncology Patients Orr, Hillary Trone, Deni Elder, Joshua Raj, Ashok Children (Basel) Brief Report This was a retrospective audit assessing vancomycin dosing of 60 mg/kg/day in the attainment of therapeutic concentrations between 10–20 mcg/mL among 56 pediatric oncology patients. Twelve patients (21%) achieved therapeutic concentrations of 10–20 mcg/mL, while 44 patients (79%) obtained trough levels below 10 mcg/mL despite the addition of nephrotoxic agents. MDPI 2017-08-28 /pmc/articles/PMC5615269/ /pubmed/28846665 http://dx.doi.org/10.3390/children4090079 Text en © 2017 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Brief Report Orr, Hillary Trone, Deni Elder, Joshua Raj, Ashok Assessment of Initial Vancomycin Dosing in Pediatric Oncology Patients |
title | Assessment of Initial Vancomycin Dosing in Pediatric Oncology Patients |
title_full | Assessment of Initial Vancomycin Dosing in Pediatric Oncology Patients |
title_fullStr | Assessment of Initial Vancomycin Dosing in Pediatric Oncology Patients |
title_full_unstemmed | Assessment of Initial Vancomycin Dosing in Pediatric Oncology Patients |
title_short | Assessment of Initial Vancomycin Dosing in Pediatric Oncology Patients |
title_sort | assessment of initial vancomycin dosing in pediatric oncology patients |
topic | Brief Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5615269/ https://www.ncbi.nlm.nih.gov/pubmed/28846665 http://dx.doi.org/10.3390/children4090079 |
work_keys_str_mv | AT orrhillary assessmentofinitialvancomycindosinginpediatriconcologypatients AT tronedeni assessmentofinitialvancomycindosinginpediatriconcologypatients AT elderjoshua assessmentofinitialvancomycindosinginpediatriconcologypatients AT rajashok assessmentofinitialvancomycindosinginpediatriconcologypatients |